US 12250931
Genetically modified mouse with a humanized PNPLA3 gene and methods of use
granted A61KA61K49/0008
Quick answer
US patent 12250931 (Genetically modified mouse with a humanized PNPLA3 gene and methods of use) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K49/0008